International CRO Cromsource has opened an office in Paris, France.

“With more than 33% of international phase II and III studies being performed here, France is a key strategic country for Cromsource,” said Christian Milla, global head of the medical division and director of operations, France. “Being on the French Ministry of Research (FMR) list of approved CROs also means many of our clients can claim tax credits for R&D activities executed by Cromsource on their behalf.”

Margherita Mosconi, director of client project development, said, “There is a high demand in France from smaller biopharmaceutical and medical technology companies for knowledgeable partners who can support them and keep within timelines and budgets.”